Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

HP-F2: Applied Tumor Immunity, Bioinformatics, and Stress Response in Stem Cells

Type: Practical Course with Student Seminars

part I: CARTs & AAVLPs: immunologic weapons against cancer

Date: 4.-8. November 2024

Host/Supervisors: Patrick Schmidt and co-workers

 

Topics:

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer. By activating a patient’s own immune system, especially CAR T cell therapy achieved success in specifically eradicating tumor cells of hematologic malignancies. However, CAR T cells are sharp weapons that may overshoot or miss their target which often leads to life-threatening consequences. Thus, in order to offer a safe and efficient immunotherapy, CAR T cells need to be precisely controlled. One way to do so is the development of AAV-based virus-like particles (AAVLPs) that structurally mimic the cellular target of a CAR. The specific CAR-AAVLP interaction leads to temporal unavailability of the CAR on the T cell surface which is directly linked to reduced cytotoxic activity of the T cell. Likewise, a control of undesired cross-reactivity of CAR T cells by designer AAVLPs could be anticipated for future use in cancer immunotherapy.

Content:

• Isolation, sorting and activation of T cells from whole blood by Ficoll gradient
• Lentiviral transduction of T cells with CARs, expression analysis (FACS) and assessment of killing activity by xcelligence assay
• Small scale AAVLP production, characterization by western blot and Dynabead-assay (FACS analysis)
• Medium scale AAVLP purification by density gradient ultracentrifugation and titration by ELISA
• AAVLP-competition assay with CAR+ T cell line (Transduction followed by FACS analysis)

part II: Characterization of the stress response of stem cells

Date: 20.-24. November 2023

Hosts/Supervisors: Marieke Essers, Sarah Geiger, and co-workers


Topics:

Infection is a common, natural form of stress, with which the body is regularly challenged. During infection or inflammation, cells of the immune system are responsible for fighting the invading pathogens, leading to high consumption of blood and immune cells. Restoration of the balance of the hematopoietic system following successful elimination of the infection is a crucial part of the recovery of the body. Restoring the balance of the hematopoietic system depends on the replacement of lost immune cells by hematopoietic stem cells (HSCs). Over the years, the biology of HSCs and their progeny has been studied in great detail during homeostasis. However little is known about how stress scenarios, such as infection-induced inflammatory responses, impact on HSC self-renewal and differentiation, controlling emergency hematopoiesis.


Content:

• isolation of stem cells
• phenotypic characterization of the stem cell response (FACS analysis, immunofluorescence)
• analysis of transcriptional and protein changes using qPCR and western blot
• functional consequences of the stress response

part III: Analysis of differential expression using RNA-seq data

Date: 2.-6. December 2024

Hosts/Supervisors: Cihan Erkut, Larissa Frasch

 

Topics:

High-throughput technologies have become essential tools in almost every biomedical research field. These techniques allow to perform a large number of measurements simultaneously, and thus enable the profiling of biological systems at unprecedented speed and resolution.
One example is gene expression profiling, where the expression levels of thousands of genes are determined in parallel to create a global picture of the cellular state. The comparison of expression profiles to determine differential expression between healthy and diseased cells can reveal detailed insights into the biology of the disease.

Content:

  • Experimental design
  • Processing of RNA-seq data
  • Statistical considerations
  • Diagnostic plots and result visualization
  • Annotation and downstream analysis

to top
powered by webEdition CMS